Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
Outcome
In 2024, FTC took enforcement action against Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) resulting in $7,000,000,000 in penalties/judgments.
Details
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) — $7,000,000,000 FTC Enforcement Action
Outcome: In 2024, FTC took enforcement action against Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) resulting in $7,000,000,000 in penalties/judgments.
Case Summary: Title: Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) URL Source: https://www.ftc.gov/legal-library/browse/cases-proceedings/221-0114-caremark-rx-zinc-health-services-et-al-matter-insulin Published Time: 2024-09-20T09:18:02-04:00 Markdown Content: # Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin) | Federal Trade Commission Skip to main content !Image 1: U.S. flag An official website of the United States government Here’s how you know Here's how you know 
How Crucible Prevents This
Crucible's continuous compliance monitoring would have flagged the regulatory gaps that led to this FTC enforcement action — through automated rule-adherence checks, consumer protection compliance tracking, and corrective action plan enforcement — preventing the violations before they triggered federal action.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works